The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection remains high for at least six months after…
Search / 13 results found Showing: 1-10 of 13
The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine confirms its protection lasts at least six months after the second dose.
Drug giant AstraZeneca updated its data on how well its coronavirus vaccine works, saying late Wednesday the vaccine showed 76% efficacy against symptomatic coronavirus disease and 100% efficacy against severe or critical disease or the need for hospitalization.
Johnson & Johnson's COVID-19 vaccine is now being administered in parts of the US.
With Johnson & Johnson's COVID-19 vaccine on the verge of being authorized for emergency use by the US Food and Drug Administration, Americans are taking another look at the vaccine and its data. And what they see might initially give them pause.
The World Health Organization has approved the Pfizer/BioNTech vaccine for emergency use, paving the way for lower and middle-income countries to begin immunizing their populations against Covid-19.
Vice President-elect Kamala Harris is expected to receive the first dose of a Covid-19 vaccine on Tuesday, according to the Biden transition team.
A critical care nurse was the first person in New York and among the first people in the United States to get a shot of the coronavirus vaccin…
An experimental coronavirus vaccine developed by Chinese state-owned pharmaceutical giant Sinopharm has 86% efficacy, the United Arab Emirates Health Ministry said in a statement Wednesday.